1 in 4 people can't get mental health help. A Warren clubhouse is changing that. - ClickOnDetroit | WDIV Local 4
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Local NewsOctober is Mental Health Awareness MonthOctober is Mental Health Awareness Month—and this Saturday is World Mental Health Day. More than 1 in 5 American adults experience mental illness every single year -- that’s more than 60 million people. 1 in 4 of those people say they cannot get the help they need. On average, people wait 11 years from their first symptoms before they ever receive treatment. One of the biggest factors in mental health is something much simpler than most people realize: Connection. Belonging. Community.1 in 6 people worldwide struggle with loneliness. And research shows that isolation makes mental health significantly worse. That is where Crossroads Clubhouse in Warren comes in. Part of Macomb County Community Mental Health, Crossroads creates a real community for adults with severe and persistent mental illness. A place to belong, to build skills and to do meaningful work. Jennifer Zimmerman, Crossroads’ program director, joined Local 4 Live to talk more about the program. You can watch the full interview in the video at the beginning of this article. Copyright 2026 by WDIV ClickOnDetroit - All rights reserved.
This article is an excerpt. To read the full content, visit the original source. ClickOnDetroit | WDIV Local 4
Related articles
World Health Organization says Russian lab worker’s death has not been clearly linked to plague - ClickOnDetroit | WDIV Local 4
HealthAbout 200 people who had contact with the worker were quarantined as officials investigated the illnessWhat to know:The World Health Organization says Russian authorities have reported no confirmed plague cases in the Irkutsk region. A worker at a Siberian research institute that studies plague died Oct. 2 after developing pneumonia. Officials have not publicly confirmed what caused her death. People who had contact with the worker were monitored and quarantined. Russian officials said testing had not found plague among those contacts. The death has sparked comparisons to COVID-19 and speculation on social media, but there is no public evidence confirming a plague infection or a broader outbreak. The World Health Organization says Russian authorities have reported no plague cases in the Irkutsk region. The worker’s cause of death remains unclear. A worker at a Siberian research institute that studies plague died after developing pneumonia, prompting officials to monitor and quarantine people who had contact with her and renewing questions about a disease many associate with the Middle Ages. But Russian authorities have reported no plague cases in the region.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!